The landscape of dementia analysis has developed considerably with the advent of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-dependent checks that may detect Alzheimer's pathology a long time in advance of signs or symptoms arise. Whilst these technological innovations signify impressive development in comprehension neurodegen